The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer

Cancer

Volumn 103, Issue 2, 2005, Pages 377-382

  Brown, Duncan J F ^a   McMillan, Donald C ^b   Milroy, Robert ^c  

^a St Columba's Hospice   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c STOBHILL HOSPITAL   (United Kingdom)

Author keywords

Depression; Fatigue; Lung cancer; Performance status; Physical function; Psychological distress; Systemic inflammatory response

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; HEMOGLOBIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY COMPOSITION; BODY MASS; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATINE KINASE BLOOD LEVEL; DISTRESS SYNDROME; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; GRIP STRENGTH; HEMOGLOBIN DETERMINATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE COUNT; LUNG CANCER; MALE; MULTIPLE REGRESSION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANXIETY; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; DEPRESSIVE DISORDER; EXERCISE TOLERANCE; FATIGUE; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PAIN MEASUREMENT; PROBABILITY; QUALITY OF LIFE; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 12344317715     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20777     Document Type: Article

References (26)

1. Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol. 1997;34:4-12.
2. Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist. 2000;5:353-360.
3. Stasi R, Abriani L, Beccaglia P, Terzoli, E, Amadori, S. Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer. 2003;98:1786-1801.
4. Scott HR, McMillan DC, Forrest LM, Brown DJ, McArdle CS, Milroy R. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer. 2002;87:264-267.
5. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63-74.
6. Neuenschwander H, Bruera E. Asthenia-cachexia. In: Bruera E, Higginson I, editors. Cachexia-anorexia in cancer patients. Oxford: Oxford University Press, 1996:57-75.
7. McMillan DC, Scott HR, Watson WS, Preston T, Milroy R, McArdle CS. Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer. 1998;31:101-105.
8. O'Gorman P, McMillan DC, McArdle CS. Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer. 1998;32:76-80.
9. Morant R. Asthenia: an important symptom in cancer patients. Cancer Treat Rev. 1996;22(Suppl A):117-122.
10. Scott HR, McMillan DC, Brown DJ, Forrest LM, McArdle CS, Milroy R. A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Cancer. 2003;40:295-299.
11. Bruera E, Brenneis C, Michaud M, et al. Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer. J Pain Symptom Manage. 1989;4:59-63.
12. Morant R, Stiefel F, Berchtold W, Radziwill A, Riesen W. Preliminary results of a study assessing asthenia and related psychological and biological phenomena in patients with advanced cancer. Support Care Cancer. 1993;1:101-107.
13. Visser MR, Smets EM. Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer. 1998;6:101-108.
14. Stone P, Richards M, A'Hern R, Hardy J. Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage. 2001;22:1007-1015.
15. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376.
16. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980;45:2220-2224.
17. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky performance status scale. An examination of its reliability and validity in a research setting. Cancer. 1984;53:2002-2007.
18. Bassey EJ, Fiatarone MA, O'Neill EF, Kelly M, Evans WJ, Lipsitz LA. Leg extensor power and functional performance in very old men and women. Clin Sci (London). 1992;82:321-327.
19. Gillies E, Aitchison T, MacDonald J, Grant S. The effects of functional training on functional tests in the elderly. Physiotherapy. 1999;85:349-357.
20. Hopwood P, Howell A, Maguire P. Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer. 1991;64:353-356.
21. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer. 1994;30A:37-40.
22. Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A'Hern R. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer. 1999;79:1479-1486.
23. Le Fevre P, Devereux J, Smith S, Lawrie SM, Cornbleet M. Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med. 1999;13:399-407.
24. Lloyd-Williams M, Friedman T, Rudd N. An analysis of the validity of the Hospital Anxiety and Depression Scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage. 2001;22:990-996.
25. Staal van den Brekel AJ, Dentener MA, Schols AM, Buurman WA, Wouters EF. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol. 1995;13:2600-2605.
26. Scott HR, McMillan DC, Watson WS, Milroy R, McArdle CS. Longitudinal study of resting energy expenditure, body cell mass and the inflammatory response in male patients with non-small cell lung cancer. Lung Cancer. 2001;32:307-312.